Fact CheckerSign in

NCT06514092Completed

Study on the Long-Term Risk of Recurrence of Anoperineal Fistula in Crohn's Disease

Study on the Long-Term Risk of Recurrence of Anoperineal Fistula After Treatment With Anti-tumor Necrosis Factor (TNF) and Seton Drainage in Crohn's Disease : LT-SAFCD

Source: ClinicalTrials.gov · Last updated 12 May 2026

Brief summary (registry, in English)

This research aims to evaluate the long-term recurrence risk of perianal fistulas in Crohn's disease patients who have undergone treatment with anti-TNF therapy and seton drainage.The research seeks to identify factors influencing recurrence and assess the long term effectiveness of these treatments in preventing fistula recurrence. This study will provide insights that could enhance treatment strategies and improve patient outcomes.

Status (registry)
Completed
Study type
Observational
Enrollment
63 (actual)
First submitted
11 Jul 2024
Start date
17 Sept 2024
Primary completion date
29 May 2025
Lead sponsor
University Hospital, Toulouse
NCT number
NCT06514092

What you commit to

  • Study type: Observational
  • Participants enrolled: 63
  • From 17 Sept 2024 to the primary completion date, 29 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient followed less than 6 months after seton drainage

Who the study is looking for

  • Confirmed diagnosis of Crohn's disease
  • drainage of an anal fistula with seton combined with the initiation of anti-TNF alpha treatment
  • Patient who was treated in the digestive center of the Toulouse University Hospital for drainage of an anal fistula between January 1, 2000 and December 31, 2010

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Toulouse
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.